BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 31387805)

  • 21. [Expression of CD4(+) and IL-17, Foxp3 in non-small cell lung cancer and their correlation with microvessel density].
    Zhang GQ; Han F; Fang XZ; Ma XM
    Zhonghua Zhong Liu Za Zhi; 2012 Aug; 34(8):596-9. PubMed ID: 23158993
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Expression of LYVE-1 and Prox-1 in non-small cell lung cancer and the relationship with lymph node metastasis].
    Chang C; Wang P; Yang H; Li L; Zhang LB
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Mar; 42(2):174-8. PubMed ID: 21500548
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
    Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
    Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High expression of SRY-box transcription factor 30 associates with well differentiation, absent lymph node metastasis and predicts longer survival in nonsmall-cell lung cancer patients.
    Liu C; Liu Y; Tian J; Zhang S; Li X; Zhai X; Feng Q
    Medicine (Baltimore); 2020 May; 99(20):e20122. PubMed ID: 32443323
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation between loss of Smad4 and clinical parameters of non-small cell lung cancer: an observational cohort study.
    Guo X; Li M; Wang X; Pan Y; Li J
    BMC Pulm Med; 2021 Apr; 21(1):111. PubMed ID: 33794845
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Co-downregulation of PTEN, KAI-1, and nm23-H1 tumor/metastasis suppressor proteins in non-small cell lung cancer.
    Goncharuk VN; del-Rosario A; Kren L; Anwar S; Sheehan CE; Carlson JA; Ross JS
    Ann Diagn Pathol; 2004 Feb; 8(1):6-16. PubMed ID: 15129904
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduced expression of liver kinase B1 and Beclin1 is associated with the poor survival of patients with non-small cell lung cancer.
    Jiang L; Liang X; Liu M; Wang W; Ma J; Guo Q; Han L; Yang C; Nan K
    Oncol Rep; 2014 Nov; 32(5):1931-8. PubMed ID: 25175672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of flotillin-2 in human non-small cell lung cancer and its correlation with tumor progression and patient survival.
    Wang YL; Yao WJ; Guo L; Xi HF; Li SY; Wang ZM
    Int J Clin Exp Pathol; 2015; 8(1):601-7. PubMed ID: 25755751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High expression of MAGE-A9 in tumor and stromal cells of non-small cell lung cancer was correlated with patient poor survival.
    Zhang S; Zhai X; Wang G; Feng J; Zhu H; Xu L; Mao G; Huang J
    Int J Clin Exp Pathol; 2015; 8(1):541-50. PubMed ID: 25755744
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SATB1 Level Correlates with Ki-67 Expression and Is a Positive Prognostic Factor in Non-small Cell Lung Carcinoma.
    Glatzel-Plucinska N; Piotrowska A; Grzegrzolka J; Olbromski M; Rzechonek A; Dziegiel P; Podhorska-Okolow M
    Anticancer Res; 2018 Feb; 38(2):723-736. PubMed ID: 29374696
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HSP90B1 overexpression predicts poor prognosis in NSCLC patients.
    Xu Y; Chen Z; Zhang G; Xi Y; Sun R; Wang X; Wang W; Chai F; Li X
    Tumour Biol; 2016 Oct; 37(10):14321-14328. PubMed ID: 27599983
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metastasis-associated in colon cancer-1 and aldehyde dehydrogenase 1 are metastatic and prognostic biomarker for non-small cell lung cancer.
    Zhou L; Yu L; Zhu B; Wu S; Song W; Gong X; Wang D
    BMC Cancer; 2016 Nov; 16(1):876. PubMed ID: 27832750
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apolipoprotein E is a predictive marker for assessing non-small cell lung cancer patients with lymph node metastasis.
    An HJ; Koh HM; Song DH
    Pathol Res Pract; 2019 Oct; 215(10):152607. PubMed ID: 31472996
    [TBL] [Abstract][Full Text] [Related]  

  • 34. RBX1 expression is an unfavorable prognostic factor in patients with non-small cell lung cancer.
    Xing R; Chen KB; Xuan Y; Feng C; Xue M; Zeng YC
    Surg Oncol; 2016 Sep; 25(3):147-51. PubMed ID: 27566015
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FBXO25 promotes cell proliferation, invasion, and migration of NSCLC.
    Jiang GY; Zhang XP; Wang L; Lin XY; Yu JH; Wang EH; Zhang Y
    Tumour Biol; 2016 Oct; 37(10):14311-14319. PubMed ID: 27596142
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overexpression of EMMPRIN is associated with lymph node metastasis and advanced stage of non-small cell lung cancer: a retrospective study.
    Liu B; Wan Z; Sheng B; Lin Y; Fu T; Zeng Q; Qi C
    BMC Pulm Med; 2017 Dec; 17(1):214. PubMed ID: 29282042
    [TBL] [Abstract][Full Text] [Related]  

  • 37. OTUD7B and NIK expression in non-small cell lung cancer: Association with clinicopathological features and prognostic implications.
    Zhang B; Wang H; Yang L; Zhang Y; Wang P; Huang G; Zheng J; Ren H; Qin S
    Pathol Res Pract; 2016 Oct; 212(10):893-898. PubMed ID: 27499151
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of IRAK1 in lung cancer tissues and its clinicopathological significance: a microarray study.
    Zhang X; Dang Y; Li P; Rong M; Chen G
    Int J Clin Exp Pathol; 2014; 7(11):8096-104. PubMed ID: 25550857
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Expressions and significances of CRABPII and E-FABP in non-small cell lung cancer].
    Liu Q; Wang S; Xu H; Zhang S
    Zhongguo Fei Ai Za Zhi; 2013 Jan; 16(1):12-9. PubMed ID: 23327868
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IL-17A/IL-17RA promotes invasion and activates MMP-2 and MMP-9 expression via p38 MAPK signaling pathway in non-small cell lung cancer.
    Wu Z; He D; Zhao S; Wang H
    Mol Cell Biochem; 2019 May; 455(1-2):195-206. PubMed ID: 30564960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.